{"id":"https://openalex.org/W2334415233","doi":"https://doi.org/10.1158/1538-7445.am2012-4747","title":"Abstract 4747: Redirecting the endogenous immune response against prostate cancer using an antibody-recruiting small molecule","display_name":"Abstract 4747: Redirecting the endogenous immune response against prostate cancer using an antibody-recruiting small molecule","publication_year":2012,"publication_date":"2012-04-01","ids":{"openalex":"https://openalex.org/W2334415233","doi":"https://doi.org/10.1158/1538-7445.am2012-4747","mag":"2334415233"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2012-4747","doi":"https://doi.org/10.1158/1538-7445.am2012-4747","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2012-4747","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002312699","display_name":"Andrew X. Zhang","orcid":"https://orcid.org/0000-0003-0406-2404","observed_orcids":["https://orcid.org/0000-0003-0406-2404"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew X. Zhang","raw_affiliation_strings":["1Yale University, New Haven, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Yale University, New Haven, CT","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070016877","display_name":"Christopher J. Hoimes","orcid":"https://orcid.org/0000-0001-8980-2410","observed_orcids":["https://orcid.org/0000-0001-8980-2410"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher J. Hoimes","raw_affiliation_strings":["1Yale University, New Haven, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Yale University, New Haven, CT","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035742323","display_name":"Ryan P. Murelli","orcid":"https://orcid.org/0000-0002-4247-3936","observed_orcids":["https://orcid.org/0000-0002-4247-3936"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan P. Murelli","raw_affiliation_strings":["1Yale University, New Haven, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Yale University, New Haven, CT","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012106344","display_name":"W. Mark Saltzman","orcid":"https://orcid.org/0000-0002-2163-549X","observed_orcids":["https://orcid.org/0000-0002-2163-549X"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. Mark Saltzman","raw_affiliation_strings":["1Yale University, New Haven, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Yale University, New Haven, CT","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101539014","display_name":"David A. Spiegel","orcid":"https://orcid.org/0000-0002-1102-8012","observed_orcids":["https://orcid.org/0000-0002-1102-8012"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David A. Spiegel","raw_affiliation_strings":["1Yale University, New Haven, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Yale University, New Haven, CT","institution_ids":["https://openalex.org/I32971472"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I32971472"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"72","issue":"8_Supplement","first_page":"4747","last_page":"4747"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.8881999850273132,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.8881999850273132,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.07410000264644623,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.01489999983459711,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.8809999823570251},{"id":"https://openalex.org/keywords/prostate-specific-membrane-antigen","display_name":"prostate-specific membrane antigen","score":0.890999972820282},{"id":"https://openalex.org/keywords/anti-dinitrophenyl-antibodies","display_name":"anti-dinitrophenyl antibodies","score":0.7229999899864197},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.9290000200271606},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.6050000190734863},{"id":"https://openalex.org/keywords/docetaxel-combination-therapy","display_name":"docetaxel combination therapy","score":0.949999988079071},{"id":"https://openalex.org/keywords/lncap-xenografts","display_name":"LNCaP xenografts","score":0.8999999761581421},{"id":"https://openalex.org/keywords/cancer-vaccination","display_name":"cancer vaccination","score":0.4350000023841858},{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.7749999761581421},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.414000004529953},{"id":"https://openalex.org/keywords/survival-extension","display_name":"survival extension","score":0.6980000138282776},{"id":"https://openalex.org/keywords/du145-cells","display_name":"DU145 cells","score":0.5519999861717224}],"concepts":[{"id":"https://openalex.org/C2776438761","wikidata":"https://www.wikidata.org/wiki/Q5206280","display_name":"DU145","level":5,"score":0.9188922643661499},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.8343446850776672},{"id":"https://openalex.org/C2779723316","wikidata":"https://www.wikidata.org/wiki/Q6459234","display_name":"LNCaP","level":4,"score":0.8245987892150879},{"id":"https://openalex.org/C40677261","wikidata":"https://www.wikidata.org/wiki/Q21418091","display_name":"Antibody-dependent cell-mediated cytotoxicity","level":4,"score":0.6453478336334229},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6406139135360718},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5749425292015076},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5461758375167847},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5435760021209717},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5329177379608154},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.5081467628479004},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.48960739374160767},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.4586929678916931},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.45417946577072144},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.44330811500549316},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4252905249595642},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3147328197956085},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.12818264961242676}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2012-4747","doi":"https://doi.org/10.1158/1538-7445.am2012-4747","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2012-4747","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1974216005","https://openalex.org/W2277918965","https://openalex.org/W2154161540","https://openalex.org/W1560691946","https://openalex.org/W2747674589","https://openalex.org/W1977277916","https://openalex.org/W2269065903","https://openalex.org/W2003927412","https://openalex.org/W1980434967","https://openalex.org/W4409624460"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Prostate":[2,217],"cancer":[3,10,56,66,102,376],"is":[4,33,364,401],"the":[5,70,96,104,140,163,235,275,285,357,432,437],"second":[6],"leading":[7],"cause":[8],"of":[9,24,39,50,59,64,84,100,106,113,154,165,228,237,242,251,255,277,287,289,359,373,389,403,414,421,431,436],"related":[11],"deaths":[12],"in":[13,16,95,162,181,210,234,274,301,312,333,356,380,408],"American":[14,438],"males":[15],"2011.":[17],"Immunotherapy":[18],"has":[19],"emerged":[20],"as":[21,152],"a":[22,48,76,192,211,302,384,398,409,415],"method":[23],"treatment":[25,99],"against":[26],"androgen-independent":[27],"prostate":[28,55,65,71,85,101,124,375],"cancer,":[29,86],"but":[30,108],"its":[31,36],"applicability":[32],"limited":[34],"by":[35,204,310,328],"cost,":[37],"difficulty":[38],"administration,":[40],"and":[41,87,115,130,145,148,167,173,197,231,257,263,280,306,317,339,355,371,378],"potential":[42],"inherent":[43,119],"immunogenicity.":[44,120],"We":[45,320],"have":[46],"developed":[47],"class":[49],"antibody-recruiting":[51],"small":[52,399],"molecule":[53,400],"targeting":[54],"(ARM-P)":[57],"capable":[58,402],"enhancing":[60],"antibody-mediated":[61],"immune":[62,205,341,369,406],"recognition":[63,370],"cells.":[67,343,361],"ARM-P":[68,133,198,225,256,270,294,329,363,393],"targets":[69],"specific":[72],"membrane":[73,77],"antigen":[74],"(PSMA),":[75],"bound":[78],"protein":[79],"overexpressed":[80],"on":[81,184,330],"many":[82,419],"forms":[83],"simultaneously":[88],"binds":[89],"to":[90,223,249,267,298,323,366,387,412],"anti-dinitrophenyl":[91],"(DNP)":[92],"antibodies":[93,297],"present":[94],"bloodstream.":[97],"ARM-P-based":[98],"confers":[103],"advantages":[105],"immunotherapy":[107],"also":[109],"benefit":[110],"from":[111],"ease":[112],"synthesis":[114],"administration":[116],"with":[117,132,245,336],"no":[118,272],"Methods:":[121],"PSMA-positive":[122],"LNCaP":[123,160,171,229,299,331],"xenografts":[125],"were":[126,150,178],"immunized":[127],"using":[128,191],"DNP-ficoll":[129],"treated":[131],"(every":[134],"other":[135],"day),":[136],"docetaxel":[137,258],"(weekly),":[138],"or":[139],"combination":[141],"for":[142,180,315,352,440],"28":[143],"days,":[144],"tumor":[146],"mass":[147],"survival":[149,233,241,266],"used":[151,179],"measures":[153],"efficacy.":[155],"Negative":[156],"controls":[157],"included":[158],"vehicle,":[159,224],"xenograft":[161,218],"absence":[164,276,358],"immunization,":[166],"PSMA-negative":[168],"DU145":[169,176,281,353],"xenografts.":[170,282],"cells":[172,177,207,300,332,354],"PSMA":[174,316],"negative":[175],"vitro":[182],"assays":[183,335],"ARM-P.":[185],"Specifically,":[186],"antibody":[187,239],"recruiting":[188],"was":[189,208,346],"measured":[190,209],"fluorescently":[193],"labeled":[194],"anti-DNP":[195,238,296,318,337],"antibody,":[196],"mediated":[199,327],"antibody-dependent":[200],"cellular":[201],"cytotoxicity":[202],"(ADCC)":[203],"effector":[206,342,360],"standard":[212],"calcein":[213],"release":[214],"assay.":[215],"Results:":[216],"studies":[219],"show":[220],"that":[221,250,293,388,413],"compared":[222],"inhibits":[226],"growth":[227],"tumors":[230],"prolongs":[232],"presence":[236],"(median":[240],"55":[243],"days)":[244],"an":[246,260,395,405],"efficacy":[247,382],"comparable":[248,386],"docetaxel.":[252,390],"Combination":[253],"therapy":[254],"showed":[259,271,292],"enhanced":[261],"effect":[262,273],"improved":[264],"median":[265],"71":[268],"days.":[269],"DNP":[278],"immunization":[279],"To":[283],"elucidate":[284],"mechanism":[286],"action":[288],"ARM-P,":[290],"we":[291],"recruits":[295],"dose":[303],"dependent":[304],"fashion,":[305],"can":[307],"be":[308],"outcompeted":[309],"titrating":[311],"respective":[313],"ligands":[314],"antibody.":[319],"observed":[321,348],"up":[322],"40%":[324],"cell":[325],"killing":[326],"ADCC":[334],"IgG":[338],"human":[340],"Cell":[344],"death":[345],"not":[347],"under":[349],"identical":[350],"conditions":[351],"Conclusions:":[362],"able":[365],"selectively":[367],"enhance":[368],"destruction":[372],"PSMA-expressing":[374],"cells,":[377],"demonstrates":[379],"vivo":[381],"at":[383],"level":[385],"Taken":[391],"together,":[392],"presents":[394],"example":[396],"where":[397],"modulating":[404],"response":[407],"manner":[410],"similar":[411],"biologic,":[416],"while":[417],"addressing":[418],"shortcomings":[420],"biologics.":[422],"Citation":[423],"Format:":[424],"{Authors}.":[425],"{Abstract":[426],"title}":[427],"[abstract].":[428],"In:":[429],"Proceedings":[430],"103rd":[433],"Annual":[434],"Meeting":[435],"Association":[439],"Cancer":[441,452],"Research;":[442],"2012":[443],"Mar":[444],"31-Apr":[445],"4;":[446],"Chicago,":[447],"IL.":[448],"Philadelphia":[449],"(PA):":[450],"AACR;":[451],"Res":[453],"2012;72(8":[454],"Suppl):Abstract":[455],"nr":[456],"4747.":[457],"doi:1538-7445.AM2012-4747":[458]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}